脑部放疗,上午比下午敏感许多!- w' k+ |9 _! g& m4 a
8 T! R. n2 a/ T# N3 d4 S3 [" Z- i
0 L- w* P' M3 {% s: T
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
S$ r% J( J, n9 G% I4 lGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
6 w" h+ K; I% O1 r* i, k) ~9 XRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
; D% g4 J& J/ m4 S5 l$ ~; KSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
8 Z& c- f3 q- D2 E- v6 W% [& u3 n; Q/ A# e
Abstract
* D8 Z3 d0 O8 b, a; ~3 G, }BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
+ c! L. h) r. Y. X4 i2 ^1 M
' ^+ p4 E# I ^. x+ y6 HMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic." R, T* t* x0 j/ K# Y
: H" F+ l1 h9 h U" y3 P yRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).8 n8 _! W0 g. a
6 P3 |2 z$ Y' o5 r) r* _ P" Z
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series./ b z0 `6 g$ ?) k$ e
3 J4 z+ w) F! D& ~0 n/ b: M" v |